Showing results (201-210 of 329) with videos related to

Sort By:
Pageof 33
Journal of the American Heart Association|April 16, 2017
Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major BleedingDaniel Lindholm, Emil Hagström, Stefan K James, et al.
Cardiorenal Medicine|January 14, 2025
EMCREG-International Multidisciplinary Consensus Panel on Management of Hyperkalemia in Chronic Kidney Disease and Heart FailureNatalie Kreitzer, Nancy M Albert, Alpesh N Amin, et al.
American Heart Journal|May 21, 2019
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trialAxel Åkerblom, Daniel M Wojdyla, Lars Wallentin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 22, 2008
G-protein-coupled receptors as signaling targets for antiplatelet therapySusan S Smyth, Donna S Woulfe, Jeffrey I Weitz, et al.
Circulation. Cardiovascular Quality and Outcomes|September 20, 2012
Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trialSteen Husted, Stefan James, Richard C Becker, et al.
Clinical Cardiology|June 10, 2017
Relative efficacy and safety of ticagelor vs clopidogrel as a function of time to invasive management in non-ST-segment elevation acute coronary syndrome in the PLATO trialCharles V Pollack, Farideh Davoudi, Deborah B Diercks, et al.
The Annals of Pharmacotherapy|June 19, 2008
Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation ForumDavid A Garcia, Daniel M Witt, Elaine Hylek, et al.
The American Journal of Cardiology|September 6, 2011
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)Robert F Storey, Richard C Becker, Robert A Harrington, et al.
Atherosclerosis|December 14, 2019
ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trialThor Ueland, Axel Åkerblom, Tatevik Ghukasyan, et al.
Frontiers in Cardiovascular Medicine|January 10, 2022
South Asian-Specific <i>MYBPC3</i> <sup>Δ25bp</sup> Deletion Carriers Display Hypercontraction and Impaired Diastolic Function Under Exercise StressSholeh Bazrafshan, Robert Sibilia, Saavia Girgla, et al.
Pageof 33